Comprehensive Study Guide to Adrenal Cortex and Medulla Pathology
Anatomy, Histology, and Embryology of the Adrenal Glands
Location and Relationships of the Adrenal Glands
- Right Adrenal Gland:
- Located at the cranial end of the right kidney.
- Positioned dorsal to the Inferior Vena Cava (IVC).
- Positioned dorsal to the right lobe of the liver.
- Shape: Triangular.
- Left Adrenal Gland:
- Located at the medial aspect of the cranial end of the left kidney.
- Positioned medial to the spleen.
- Positioned superior to the splenic artery and vein.
- Shape: Crescentic.
- Right Adrenal Gland:
Embryology
- The Adrenal Medulla is derived from neural crest cells.
- The Adrenal Cortex is derived from the surrounding mesoderm.
- Developmental Timeline:
- ~1 Month: Development of the cortical primordium and migration of chromaffin cells.
- 2 Months: Development of the acidophilic fetal cortex.
- 4 Months: Differentiation into the zona glomerulosa, adult cortex, and medulla containing chromaffin cells.
Normal Adrenal Histology and Zonation
- Zona Glomerulosa: Outer layer; cells are arranged in round structures resembling glomeruli. It is the site of mineralocorticoid production (Aldosterone).
- Zona Fasciculata: Middle layer; cells are arranged in columns. These cells are vacuolated and foamy due to lipid content. It is the site of glucocorticoid production (Cortisol).
- Zona Reticularis: Inner layer of the cortex; cells contain brown lipofuscin pigment. It is the site of sex steroid production (Androstenedione).
Functional Zonation and Steroidogenesis
Zona Glomerulosa (Mineralocorticoid Pathway)
- Cholesterol Side-chain cleavage () Pregnenolone.
- Pregnenolone Conversion of to steroid () Progesterone.
- Progesterone () .
- DOC () Corticosterone.
- Corticosterone () .
- () Aldosterone.
- Aldosterone synthase is highly active in this zone.
Zona Fasciculata (Glucocorticoid Pathway)
- Pregnenolone () .
- .
- () .
- () Cortisol.
Zona Reticularis (Sex Steroid Pathway)
- () DHEA.
- DHEA + Sulfotransferase () DHEAS.
- DHEA Androstenedione via .
Hyperadrenalism: Cushing Syndrome and Cushing Disease
Cushing Syndrome (Increased Cortisol)
- Clinical Features and Prevalence:
- Obesity or weight gain: .
- Facial plethora: .
- Rounded face: .
- Decreased libido: .
- Thin skin: .
- Decrease in linear growth in children: .
- Menstrual irregularity: .
- Hypertension: .
- Hirsutism: .
- Depression/emotional liability: .
- Easy bruising: .
- Glucose intolerance: .
- Weakness: .
- Osteopenia or fracture: .
- Nephrolithiasis: .
- Pathophysiology of Symptoms:
- Lipase activation leads to decreased peripheral fat and increased central fat (central obesity).
- Increased protein breakdown results in steroid myopathy (type 2 fiber atrophy), osteoporosis, and purple-red abdominal/axillary striae.
- Insulin antagonism inhibits glucose uptake.
- Immune suppression results in decreased lymphocytes and eosinophils.
- Androgenic effects include acne and hirsutism.
- Hypertension is caused by intrinsic mineralocorticoid activity, activation of the renin-angiotensin system, enhancement of vasoactive substances, and suppression of vasodilatory systems.
- Clinical Features and Prevalence:
Etiology of Cushing Syndrome
- Iatrogenic: Most common cause; results from exogenous steroids (e.g., Prednisone). Leads to adrenal atrophy.
- Pituitary Cushing Syndrome (Cushing Disease): Caused by a basophil microadenoma of the pituitary secreting ACTH. Predominantly affects women; usually no mass effect. Results in bilateral adrenal hyperplasia.
- Paraneoplastic Cushing Syndrome: Ectopic ACTH production, typically by small cell carcinoma of the lung or carcinoid tumors. Results in bilateral adrenal hyperplasia.
- Adrenal Cushing Syndrome: Primary adrenal lesions including adrenal adenomas, carcinomas, or nodular hyperplasia. Cortisol is elevated, but ACTH is low.
Hyperadrenalism: Hyperaldosteronism
- Clinical Presentation: Retention of sodium (), hypokalemia (), metabolic alkalosis (low ), low renin activity, and hypertension.
- Mechanism of Action: Aldosterone increases sodium reabsorption by activating the pump in distal tubules and the epithelial sodium channel (). Hydrogen ions are lost in the intercalated cells of the collecting ducts via hydrogen ion ATPases.
- Primary Hyperaldosteronism:
- Conn Syndrome: Aldosterone-producing adenoma ( of cases). Well-demarcated yellow tumors; cells resemble the zona glomerulosa but lack the abundant lipid of the zona fasciculata.
- Idiopathic Adrenal Hyperplasia: Bilateral hyperplasia ( of cases). Not surgically correctable.
- Genetic Factors: Mutations in the potassium channel gene (encoding GIRK-4) occur in of bilateral hyperplasia and adenomas. Loss of selectivity leads to sodium influx and calcium-dependent activation of aldosterone synthase.
- Familial Forms:
- Type I: Glucocorticoid remediable (autosomal recessive).
- Type II and III: Not glucocorticoid remediable.
- Secondary Hyperaldosteronism: Caused by reduced blood flow to the kidneys (e.g., renal artery stenosis) or hypovolemia, resulting in increased renin.
Adrenal Insufficiency
- Addison’s Disease (Chronic Primary Adrenal Insufficiency)
- History: Named after Thomas Addison of Guy's Hospital, London (associated with Richard Bright and Thomas Hodgkin). Described as "general languor and debility" with skin changes.
- Clinical Features: Insidious onset, fatigue, weight loss, nausea, vomiting, hypotension, hyponatremia, hyperkalemia, and skin hyperpigmentation at pressure points (due to portion of ).
- Addisonian Crisis: Acute insufficiency triggered by stress in patients with no reserve.
- Etiology of Insufficiency:
- Autoimmune Adrenalitis: Involvement of lymphocytes in the cortex and loss of cortical cells.
- Autoimmune Polyglandular Syndrome (APS):
- APS 1: Hypoparathyroidism, candida infection, pernicious anemia, skin/nail issues.
- APS 2: Autoimmune thyroiditis or Type 1 DM in young adults.
- Infections: Tuberculosis (characterized by caseous necrosis), HIV, and Histoplasmosis (intracellular organisms).
- Adrenoleukodystrophy (ALD): X-linked (Chr ), onset age 5-6. Inability to metabolize very long chain fatty acids () due to a defective ATP-binding cassette transporter protein. Characterized by myelin loss in the cerebrum and linear lipid inclusions in adrenal cytoplasm.
- Acute Insufficiency: Shock, sepsis, and Waterhouse-Friderichsen syndrome (hemorrhagic necrosis).
- Secondary Insufficiency: Metastatic cancer, pituitary disease, amyloidosis, or steroid therapy withdrawal.
Adrenal Mass Lesions and Incidentalomas
- Incidentaloma: A lesion discovered "by surprise" during imaging for an unrelated complaint. Prevalence is approximately (age-dependent).
- Differential Diagnosis:
- Adenoma: Benign, usually clinically silent, < 2.5 cm.
- Adrenal Cortical Carcinoma: Large, necrotic, often functioning ( cause Cushing’s). Frequent metastasis at diagnosis.
- Metastasis from other sites.
- Pheochromocytoma.
- Other benign lesions: Cysts, pseudocysts, adenomatoid tumors, hemangiomas, angiomyolipomas, oncocytomas.
- Follow-Up Strategy:
- Benign: Stop testing if imaging shows a stable, fat-rich lesion or classic cyst.
- Indeterminate: Repeat CT or MRI in 6 to 12 months.
- Surgery: Referral if the mass grows quickly, appears suspicious, or is larger than 4 cm.
Pathology of the Adrenal Medulla
Medullary Histology: Centrally located basophilic cells called chromaffin cells. They secrete epinephrine and norepinephrine. They stain brown with dichromate salts (chromaffin reaction).
Pheochromocytoma
- The "Rule of 10%":
- Extra-adrenal.
- Occur in children.
- Bilateral.
- Discovered as incidentalomas.
- Malignant.
- Clinical Presentation: Hypertension, Headache, Sweating (perspiration), Palpitations/tachycardia, Tremor, Dyspnea, and Pallor.
- Associated Conditions: Multiple Endocrine Neoplasia () 2A and 2B.
- The "Rule of 10%":
Neuroblastoma
- Epidemiology: of childhood tumors; of tumors in infants. Median age: 22 months.
- Pathology: Part of the Primitive Neuroectodermal Tumor () family (small, blue, round cell tumors). Derived from the neural crest. Often bulky, necrotic, and hemorrhagic.
- Genetics: amplification (Chr ) is a poor prognostic factor, visible by .
- Diagnosis: Tumors secrete catecholamines (dopamine, epinephrine, NE). Metabolites (homovanillic acid) and (vanillylmandelic acid) are found in urine. Electron microscopy shows neurosecretory granules.
- Prognosis: Overall 5-year survival is . If diagnosed under age 2, survival is . Some tumors may spontaneously regress or differentiate into neurons (better prognosis).
Multiple Endocrine Neoplasia (MEN) Syndromes
- MEN 1 ("3 Ps"): Pituitary adenoma, Parathyroid hyperplasia, Pancreatic islet cell tumors.
- MEN 2A: Parathyroid hyperplasia, Medullary thyroid carcinoma, Pheochromocytoma.
- MEN 2B: Mucosal neuromas, Marfanoid body habitus, Medullary thyroid carcinoma, Pheochromocytoma.
Questions & Discussion
- Follow-up Inquiry: How should a physician proceed after the discovery of an incidentaloma?
- Response: The physician is obligated to make a diagnosis with follow-up testing. Benign, fat-rich lesions may require no further testing. Indeterminate masses should be scanned again in 6-12 months. Surgery is considered for growth, suspicious appearance, or size > 4 cm.
- Follow-up Inquiry: What tests are ordered for suspected hyperaldosteronism (Case 2)?
- Response: Given the high sodium, low potassium, and hypertension, follow-up would focus on measuring renin and aldosterone levels to distinguish primary from secondary causes.